DiscoveryAI is a Pune, India based startup. DiscoveryAI is on a mission to empower enterprises to improve revenue, reduce costs & improve productivity by using the best of breed Artificial Intelligence (AI) and Natural Language Processing (NLP) technologies.
Enterprise ready conversational AI platform to improve adoption of apps & reduce service calls.
AI powered customer support #chatbot #AI #customer_support #DiscoveryAI
Company details:
Website:
http://discovery.ai
Headquarters:
Pune, Maharashtra
Year founded:
2016
Company type:
Privately Held
Company size:
2-10 employees
Specialties:
#machinelearning #graphdatabase #artificialintelligence #naturallanguageprocessing
AI Blog
AI Trainings
Events
Jobs
TensorFlow is an open-source software library for dataflow programming across a range of tasks.
It is a symbolic math library, and also used for machine learning applications such as Neural Networks.
TensorFlow was developed by the Google Brain team for internal Google use. It was released under the Apache 2.0 open source license on November 9, 2015
TensorFlow™ is an open source software library for numerical computation using data flow graphs. Nodes in the graph represent mathematical operations, while the graph edges represent the multidimensional data arrays (tensors) communicated between them.
The flexible architecture allows you to deploy computation to one or more CPUs or GPUs in a desktop, server, or mobile device with a single API.
Visit:
Github Links:
https://github.com/tensorflow/tensorflow
BioBeats is a digital health and artificial intelligence business that creates corporate and personal wellness solutions.
BioBeats built a world-class team which includes renowned experts in the fields of artificial intelligence, machine learning, wearables including battery life optimisation, cloud solutions and theoretical computer science.
At our core, we provide insights into an individual’s health and wellbeing, by tracking data from wearable and smartphone sensors.
Products:
Hear And Now
https://biobeats.com/hearandnow/
Corporate Wellness
https://biobeats.com/corporate-wellness/
Funding:
Total funding so far: $3,569,500
Founders:
David Plans, Davide Morelli, Nadeem Kassam
#HealthCare #HumanResources #InformationTechnology #MachineLearning #AI
OrCam harnesses the power of Artificial Vision in an intuitive portable device that compensates for lost visual abilities.OrCam MyEye 2.0 is all about using technology to help blind and visually impaired people achieve increased independence.
OrCam’s mission is to harness the power of artificial vision by incorporating pioneering technology into a wearable platform which improves the lives of individuals who are blind, visually impaired, and have reading difficulties.
OrCam was jointly founded in 2010 by Prof. Amnon Shashua and Mr. Ziv Aviram, who are also the co-founders of Mobileye, the collision avoidance system leader and autonomous driving innovator. The original OrCam MyEye device was launched in 2015, and the next generation OrCam MyEye 2.0 was launched in 2017
Co Founder:
Prof. Amnon Shashua holds the Sachs Chair in Computer Science at the Hebrew University of Jerusalem. His field of expertise is computer vision and machine learning. For his academic achievements, he has received the Marr Prize Honorable Mention in 2001, the Kaye Innovation Award in 2004, and the Landau Award in Exact Sciences in 2005.
Mr. Aviram is one of Israel’s most esteemed managers. Before co-founding OrCam, Mr. Aviram co-founded Mobileye, an Israeli technology company that develops vision-based advanced driver-assistance systems (ADAS) providing warnings for collision prevention and mitigation. Today 90% of the world’s leading automobile manufacturers rely on Mobileye technology to make their vehicles safer to drive.
He is the co-founder of Mobileye, an Israeli technology company that develops vision-based advanced driver-assistance systems (ADAS) providing warnings for collision prevention and mitigation.
Products:
https://www.orcam.com/en/myeye2/
https://www.orcam.com/en/myeye/
News:
OrCam to Launch Next Generation of Artificial Vision
OrCam’s MyEye for the visually impaired: ‘It’s opened up a whole new world
We are an AI startup, building delightful products for cancer radiologists. Looking for beta users for our first product in Liver Cancer!
Predible Health, which runs an artificial intelligence-based cancer radiology platform, has raised an undisclosed amount from impact investor Unitus Seed Fund.
"Unitus’ funding will enable Predible to scale up the development of our cancer AI platform as well as invest in regulatory approvals for our existing products," said Predible Health chief executive Suthirth Vaidya. "Our clinical validation studies are displaying positive results and we are now working to bring our offerings into clinical practice."
The startup says it has processed more than two million images since its inception in 2016, and it is aiming to touch 500 million images by December 2020. It currently has tie-ups with healthcare institutions such as Tata Memorial Hospital in Mumbai, Mahajan Imaging in Delhi and Narayana Health in Bengaluru.
Predible Health facilitates cancer diagnosis through its artificial intelligence powered clinical applications for liver and lung cancers which enable radiologists to interpret images faster and with more accuracy. It has developed algorithms to help physicians characterise diseases as well as plan and deliver personalised treatment.
The company has developed two flagship products, including Predible Liver, which assists surgeons with precise planning for liver transplant and tumour resections through instant analysis and 3D visualisation of liver lesions and hepatic structures. Built on the cloud, the solution can be accessed by hospitals across India with an internet connection
Company details:
Website:
http://www.prediblehealth.com
Headquarters:
Bangalore, Karnataka
Year founded:
2016
Company type:
Privately Held
Company size:
11-50 employees